Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Assessment of ovarian stimulation with and without letrozole in IVF/ICSI outcomes
IRCT201701291952N8Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of letrozole in Diminished Ovarian Reserve (DOR) (2 arms), sponsored by Tehran University of Medical Sciences. Started Feb 2017; status: completed.
02
Drugs
letrozole
03
Conditions
Diminished Ovarian Reserve (DOR)
Beyond the preview
Go deeper on IRCT201701291952N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201701291952N8.